The fundamental principle of most currently available COVID-19 vaccines is to inhibit the interaction between the virus’s spike protein receptor-binding domain (RBD) and human angiotensin-converting enzyme 2 (ACE2). The gene discussed is ACE2; the disease is COVID-19.